Elevance's Pre-Q3 Earnings Analysis: Smart Buy Now or Caution Ahead?

Elevance Health, Inc. (ELV) is set to report its third-quarter 2024 results on Oct. 17, 2024, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings and revenues is pegged at $9.74 per share and $43.2 billion, respectively. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The earnings estimate for the to-be-reported quarter has witnessed downward revisions over the past 60 days. The bottom-line projection indicates year-over-year growth of 8. ...